Legislation to further protect the American people from Big Pharma’s relentless price gouging is moving in the U.S. Senate.
More progress is needed to expand access and ensure fair and affordable prices for insulin.
Upcoming drug-pricing legislation must ensure access to insulin for everyone regardless of insurance status AND include controls on Big Pharma’s price gouging and anti-competitive tactics over insulin.
Please share the petition with your network, and read our report now.
We must stop the billionaire Koch brothers from using their immense wealth to influence university research and spread their corporate-friendly ideology.